2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
PSG Releases Highly Anticipated 2024 ‘Trends in Specialty Drug Benefits Report’
DALLAS, TX – April 29, 2024 – Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Specialty Drug…
Read Post
2024 Trends in Specialty Drug Benefits Report Webinar
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to…
Read Post
2024 Trends in Specialty Drug Benefits Report
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to…
Read Post
Medicare Part D Redesign: How Health Plans Can Prepare Using CMS Guidance
CMS Guidance Can Help Plans Prepare For 2025 Medicare Part D Redesign The Centers for Medicare & Medicaid Services (CMS) recently unveiled the…
Read Post
CMS Issues Coverage Guidance on GLP-1 Anti-Obesity Drugs: Implications for Health Plans
CMS Issued Coverage Guidance on GLP-1 Anti-Obesity Drugs Requiring Considerations for Health Plans GLP-1s (glucagon-like peptide 1 agonist) came up in the news again…
Read Post
Embracing the Modular PBA Services Model: A Flexible Approach to Pharmacy Benefits Management
A Modular PBA Services Model Can Provide The Flexibility Desired By Plans The term “Modular PBA Services” is one we are all very familiar…
Read Post
Reviewing PBM Alternative Pricing Models For CVS Health, ESI, and OptumRx
PBM Alternative Pricing Models Require Thoughtful Consideration For Plan Sponsors PBM alternative pricing models are being rolled out by some of the biggest organizations…
Read Post
A Clinical Playbook Driven By Integrated Data
Your Definitive Guide to Ensuring Peak Performance of Your Pharmacy Program Managing the pharmacy program has never been more complex for plan sponsors. Innovative…
Read Post
Medicare Part D Redesign is Here: Changes to Medicare Formularies for 2025
The 2025 bid planning season is in full swing, and Medicare plans are feeling the pressure here and now from the…
Read Post
Q&A: Challenges and Solutions for Specialty Drug Benefits
In the complex landscape of healthcare, the escalating costs of drugs have become a pressing concern. To learn more about how pharmacy managed care…
Read Post
CVS Caremark Removes Humira From Formulary: What It Means For The Market
CVS Announces The Removal of Humira From Its Formulary On January 3, 2024, CVS Caremark announced it will be removing brand Humira from several…
Read Post